Forbes
Forbes
@forbes·2.1M subscribers·11.3K videos

This Next Billion-Dollar Startup Makes Longevity Drugs For Dogs (And What It Could Mean For Humans)

Posted

August 12, 2025

Views

7,580

Likes

115

Comments

23

Engagement

1.82%

Search the Record

Indexed

Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.

Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.

Try a name, a topic, or a quoted line

Chapters

YouTube Description

as posted by the channel

Uncover the future of aging with Loyal, the biotech company leading a quiet revolution. Led by founder Celine Halioua, Loyal is unravelling the fundamental mechanisms of pathological aging in our beloved companions. Their mission? To extend the healthy lives of dogs and, in doing so, reveal unprecedented insights into human longevity.

Loyal joins the 2025 Forbes Next Billion-Dollar Startups list and involves the largest animal clinical trial ever conducted, enrolling 1,300 dogs across 70 veterinary clinics nationwide. The goal: to give dogs "one healthier year" and yield a "gold mine of data" that will fundamentally advance the understanding of aging in both canines and humans.

Could the secret to a longer, healthier human lifespan be found in the journey of our canine companions? Loyal's unofficial slogan hints at the profound answer: "save the dogs, save the world".

Read the full story on Forbes

Subscribe to FORBES

Fuel your success with Forbes. Gain unlimited access to premium journalism, including breaking news, groundbreaking in-depth reported stories, daily digests and more. Plus, members get a front-row seat at members-only events with leading thinkers and doers, access to premium video that can help you get ahead, an ad-light experience, early access to select products including NFT drops and more:

Stay Connected

Forbes newsletters

Forbes on Facebook

Forbes Video on Twitter

Forbes Video on Instagram

More From Forbes

Forbes covers the intersection of entrepreneurship, wealth, technology, business and lifestyle with a focus on people and success.

Guests & Subjects Covered

Celine Halioua LoyalForbes Next Billion-Dollar StartupsForbes SubscribeOur Two ApproachesThe Science KeepingWhy We FocusFoundational BiologyLargest Clinical Trial

Sentinel Indexing in Progress

Metadata and chapters are available. Claim extraction for this episode is pending.

All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.

This Next Billion-Dollar Startup Makes Longevity Drugs For Dogs (And What It Could Mean For Humans) · Forbes · Sentinel